No black box warning on record for Sevenfact

As of the latest FDA labeling reviewed, Sevenfact (COAGULATION FACTOR VIIA RECOMBINANT HUMAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Sevenfact medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Patients with hemophilia A or B with inhibitors who have other risk factors for thrombosis may be at increased risk of serious arterial and venous thrombotic events ( 5.1 ). Hypersensitivity reactions, including anaphylaxis, are possible with SEVENFACT. Should symptoms occur, patients should discontinue SEVENFACT and seek appropriate medical intervention ( 5.2 ). 5.1 Thr

No black box warning on record for Sevenfact

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Patients with hemophilia A or B with inhibitors who have other risk factors for thrombosis may be at increased risk of serious arterial and venous thrombotic events ( 5.1 ). Hypersensitivity reactions, including anaphylaxis, are possible with SEVENFACT. Should symptoms occur, patients should discontinue SEVENFACT and seek appropriate medical intervention ( 5.2 ). 5.1 Thr

Sevenfact Black Box Warning

No black box warning on record for Sevenfact

Other warnings & precautions

Sevenfact Black Box Warning

No black box warning on record for Sevenfact

Other warnings & precautions